Catabolic effect of dexamethasone in the preterm baby.

K G Brownlee, P C Ng, M J Henderson, M Smith, J H Green, P R Dear

Department of Paediatrics and Child Health, St James's University Hospital, Leeds.

Most babies treated with dexamethasone for bronchopulmonary dysplasia exhibit an appreciable rise in the blood urea concentration, from a mean of 2.3 mmol/l before steroid to a mean of 7.1 mmol/l after. In order to discover whether this was primarily the result of increased protein catabolism, nitrogen balance studies before and after the start of dexamethasone were performed and a mean deficit in nitrogen retention of 158 mg/kg/24 hours was found. Similarly the urinary 3-methylhistidine (3MH):creatinine ratio before and after the commencement of dexamethasone treatment in a group of preterm babies was measured. It was found that there was a substantial increase in 3MH excretion after dexamethasone: from a mean 3MH:creatinine ratio of 46 in the week before steroids to a mean ratio of 77 in the week after. As 3MH emanates almost exclusively from the breakdown of actin in skeletal muscle cell, this finding implies the loss of muscle tissue. It was also found that the babies were in less positive nitrogen balance after dexamethasone, to a degree which is significant relative to their protein reserves. The long term consequences of a period of increased catabolism are not yet known but the authors suggest caution in the use of dexamethasone, at least in babies with milder degrees of bronchopulmonary dysplasia in whom the ratio of benefit to risk may be less favourable.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Catabolic effect of dexamethasone in the preterm baby.

Y L Chang
Arch. Dis. Child. 1992 67: 885. [PDF]

This article has been cited by other articles:

• Bunt, J. E. H., Rietveld, T., Schierbeek, H., Wattimena, J. L. D., Zimmermann, L. J. I., van Goudoever, J. B. (2007). Albumin synthesis in preterm infants on the first day of life studied with [1-13C]leucine. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1157-G1161 [Abstract] [Full Text]  
• Neal, C. R. Jr., Weidemann, G., Kabbaj, M., Vazquez, D. M. (2004). Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R375-R385 [Abstract] [Full Text]  
• Flagel, S. B., Vazquez, D. M., Watson, S. J. Jr., Neal, C. R. Jr. (2002). Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: R55-R63 [Abstract] [Full Text]  
• O'Shea, T. M., Kothadia, J. M., Klinepeter, K. L., Goldstein, D. J., Jackson, B. G., Weaver, R. G. (1999). Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted Age. Pediatrics 104: 15-21 [Abstract] [Full Text]  
• Kothadia, J. M., O'Shea, T. M., Roberts, D., Auringer, S. T., Weaver, R. G., Dillard, I.{s. a. R. G. (1999). Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants. Pediatrics 104: 22-27 [Abstract] [Full Text]  
• Skelton, R, Gill, A B, Parsons, J M (1998). Cardiac effects of short course dexamethasone in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 78: 133F-137 [Abstract] [Full Text]